Who we are
We’re an ALK+ patient and family-led organisation, consisting of the charity trustees and an advocacy and advisory committee.
What do we do?
Our aim is simple:
To improve the life expectancy for ALK+ cancer patients.
We will do this by:
Fundraising, we can help drive more of the most vital research for ALK+ patients by providing grants for projects and clinical trials.
Advocating for improvements to treatment and clinical trial availability, with government, pharmaceutical companies, regulatory bodies and other organisations.
Working with relevant charities, medical professionals, government and regulatory bodies, we will effect change among decision makers using our knowledge and experience of ALK+ cancers.
Keeping abreast of trials, breakthroughs and technologies internationally in the oncology industry, we will better advocate for patients and help accelerate the introduction of lifesaving ALK+ advances.
Support ALK+ International and join the conversation online.